LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 159 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $50,588,000 | +11.8% | 472,386 | +12.9% | 0.09% | +12.7% |
Q4 2015 | $45,266,000 | +42.3% | 418,475 | +12.7% | 0.08% | +33.9% |
Q3 2015 | $31,814,000 | -3.4% | 371,436 | +13.8% | 0.06% | +11.3% |
Q2 2015 | $32,944,000 | +14.7% | 326,514 | -12.4% | 0.05% | 0.0% |
Q1 2015 | $28,732,000 | +62.4% | 372,609 | +10.0% | 0.05% | +71.0% |
Q4 2014 | $17,696,000 | +19.7% | 338,855 | +7.7% | 0.03% | +19.2% |
Q3 2014 | $14,782,000 | +36.7% | 314,559 | +43.2% | 0.03% | +36.8% |
Q2 2014 | $10,816,000 | -14.4% | 219,635 | +16.9% | 0.02% | -13.6% |
Q1 2014 | $12,633,000 | +21.7% | 187,814 | +9.1% | 0.02% | +15.8% |
Q4 2013 | $10,378,000 | +273.4% | 172,129 | +168.0% | 0.02% | +280.0% |
Q3 2013 | $2,779,000 | 0.0% | 64,223 | -13.5% | 0.01% | 0.0% |
Q2 2013 | $2,779,000 | – | 74,229 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
RK Capital | 127,983 | $13,876,000 | 2.42% |
Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |